Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Notice of Conference Call the Day Before

<< Previous

Bullboard Posts

Next >>

Comment by Investor5876on Nov 11, 2024 2:05pm

101 Views

Post# 36306972

RE:RE:RE:Notice of Conference Call the Day Before

There is a good chance that a news release will come at the end of trading today announcing a partnership.

It is certainly unusal for ONC to issue notificaion of quarterly earnings only one day prior to the conference call.

I'd love to see a bit of a run up in the SP this afternoon!

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch